MedPath

Impact of Number of Rank of B-lactam Antibiotics on Emergence on Multidrug Resistant Bacteria

Conditions
Resistant Infection
Antibiotic Resistant Infection
Beta Lactam Resistant Bacterial Infection
Bacterial Resistance
Interventions
Procedure: number of Beta lactam class prescription for the same infection
Registration Number
NCT03752476
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

This study evaluates the impact of rank of Beta lactam antibiotics on emergence of mutlidrug resistant bacteria colonization in intensive care

It's retrospective case controle study. Cases are colonized patient by multidrug resistant bacteria hospitalized in intensive care during the fist hospitalization in intensive care. Temoin are patients with the same characteristics than case but no colonized by multidrug resistant bacteria.

Detailed Description

The emergence of multidrug resistant is a wordwide problem. B lactam resistant increase. The antibiotic prescription impact this problem.

B lactam antibiotic is prescribed everyday in intensive care unit. The switch of antibiotic is common. Antibiotic classes inclue a lot of rank with different spectum that impact the occurrence of resistant.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1300
Inclusion Criteria
  • all patient hospitalized more than 48 hours in intensive care unit in Besançon between january 2016 and december 2017
Exclusion Criteria
  • patient under guardianship
  • patient allergic to Beta lactam
  • colonization with mutidrug resistant the first week of hospitalization in intensive care unit

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
casenumber of Beta lactam class prescription for the same infectionPatients are colonized patient by antimicrobial bacteria hospitalized in intensive care during the fist hospitalization in intensive care during 2016-2017.
controlnumber of Beta lactam class prescription for the same infectionPatients aren't colonized patient by antimicrobial bacteria hospitalized in intensive care during the fist hospitalization in intensive care during 2016-2017.
Primary Outcome Measures
NameTimeMethod
number of Beta lactam class prescription3 months
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath